Testing a new immune-blocking treatment for chronic lung disease

This trial is testing a medication called tezepelumab to see if it can reduce inflammation in the airways of people with COPD. The medication works by blocking a specific immune signal that triggers airway swelling and flare-ups. Researchers want to understand whether this treatment can help people who have had at least one serious COPD flare-up in the past year.

COPD flare-ups can be serious and disruptive, and current treatments don't work well enough for everyone. This medication targets a new part of the immune system that hasn't been used in COPD treatment before, and early research suggests it might help prevent these painful, dangerous flare-ups.